21 – 30 of 165
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Mapping the Past : Geographically Linking an Early 20th Century Swedish Encyclopedia with Wikidata
2024) Joint 30th International Conference on Computational Linguistics and 14th International Conference on Language Resources and Evaluation, LREC-COLING 2024 In 2024 Joint International Conference on Computational Linguistics, Language Resources and Evaluation, LREC-COLING 2024 - Main Conference Proceedings p.11040-11048(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
How does an AI diagnose dyspnoea in ED triage without human guidance?
2024) Swedish Emergency Medicine Talks - SWEETS24(
- Contribution to conference › Poster
-
Mark
Prior electrocardiograms not useful for machine learning predictions of major adverse cardiac events in emergency department chest pain patients
(
- Contribution to journal › Article
-
Mark
The skåne emergency medicine (SEM) cohort
(
- Contribution to journal › Article
-
Mark
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1) : a multicentre, randomised, phase 2 trial
(
- Contribution to journal › Article
-
Mark
The Concordance Index decomposition : A measure for a deeper understanding of survival prediction models
(
- Contribution to journal › Article
-
Mark
Intraductal papillary neoplasms of the bile ducts : a comparative study of a rare disease in Europe and Nagoya, Japan
(
- Contribution to journal › Article
-
Mark
Transatlantic differences in the use and outcome of minimally invasive pancreatoduodenectomy : an international multi-registry analysis
(
- Contribution to journal › Article
-
Mark
Impact of Neoadjuvant Therapy for Pancreatic Cancer : Transatlantic Trend and Postoperative Outcomes Analysis
(
- Contribution to journal › Article
- 2023
-
Mark
Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study
(
- Contribution to journal › Article